CUTANEOUS LUPUS
Clinical trials for CUTANEOUS LUPUS explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human tests begin for promising new autoimmune disease drug
Disease control Recruiting nowThis early-stage study is testing a new drug called SAR448501 in adults with moderate-to-severe lupus or rheumatoid arthritis who haven't gotten enough relief from their current treatments. The main goal is to find safe dose levels and see how the drug behaves in the body. About …
Matched conditions: CUTANEOUS LUPUS
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Tracking 1,000 pregnancies to unlock healthier outcomes for moms with autoimmune conditions
Knowledge-focused Recruiting nowThis study is creating a registry to learn more about how autoimmune diseases affect pregnancy. It will follow 1,000 pregnant women with conditions like lupus or rheumatoid arthritis to identify risk factors for complications. The goal is to gather information that can help impro…
Matched conditions: CUTANEOUS LUPUS
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Duke launches major lupus tracking project to unlock better treatments
Knowledge-focused Recruiting nowThis study is creating a long-term registry to track how lupus changes over time in patients treated at Duke. Researchers will collect health information and optional blood samples during regular clinic visits from 1000 participants. The goal is to gather data to understand the d…
Matched conditions: CUTANEOUS LUPUS
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:53 UTC